Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

JOURNAL ARTICLE

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases

Michael Rader, Carsten Goessl, Ze Cong

Journal of Managed Care Pharmacy: JMCP 2012, 18 (1): 74-5; author reply 75-6

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

You are not logged in. Sign Up or Log In to join the discussion.

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases. Jipan Xie, Madhav Namjoshi, Eric Q Wu, Kejal Parikh, Melissa Diener, Andrew P Yu, Amy Guo, Kenneth W Culver Journal of Managed Care Pharmacy: JMCP 2011, 17 (8): 621-43

Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer. John A Carter, Marc F Botteman Expert Review of Pharmacoeconomics & Outcomes Research 2012, 12 (4): 425-37

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. Alison Stopeck, Michael Rader, David Henry, Mark Danese, Marc Halperin, Ze Cong, Yi Qian, Roger Dansey, Karen Chung Journal of Medical Economics 2012, 15 (4): 712-23

Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours. John A Carter, Avani D Joshi, Satyin Kaura, Marc F Botteman PharmacoEconomics 2012, 30 (5): 373-86

Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer. Athanasios Dellis, Athanasios Papatsoris Expert Review of Pharmacoeconomics & Outcomes Research 2016, 16 (1): 5-10

Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastases. Jipan Xie, Melissa Diener, Rachael Sorg, Eric Q Wu, Madhav Namjoshi Clinical Breast Cancer 2012, 12 (4): 247-58

Make the most of Read.
Download the mobile app.

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read